Register now for this CME event, Feb. 20–21
Now more than ever, innovations in diagnostic tests, therapies and surgical technologies are influencing care options for patients with diabetes mellitus and thyroid disorders. Learn more about the latest advances and get a glimpse of what lies ahead at:
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
February 20–21, 2015
Cleveland Clinic Florida’s Jagelman Conference Center
Weston, Florida
Cleveland Clinic is one of the top medical centers with experts in the management of diabetes and thyroid disorders.
The two-day agenda features lectures, panel discussions and question and answer sessions, as well as these keynote addresses:
Prevention of Type 2 Diabetes Mellitus
by Ronald Goldberg, MD, professor of medicine
Division of Endocrinology Diabetes and Metabolism
Diabetes Research Institute
University of Miami Miller School of Medicine
Epidemiology and Update on Thyroid Nodules
by R. Mack Harrell, MD, FACP, FACE, ECNU
Co-Founder, Memorial Center for Integrative Endocrine Surgery
President, American Association of Clinical Endocrinology
Attendees will learn about:
This course is designed for physicians, nurses, diabetes educators, residents, fellows and other health care professionals in primary care as well as endocrinology, surgery, otolaryngology, pathology, nuclear medicine, genomics and other specialties.
Advertisement
Physicians can claim up to 12.50 AMA PRA Category 1 Credits™ for this activity and may submit CME credit hours to the American Osteopathic Association for Category 2 credits. Nurses can claim up to 14 CEUs by the Florida Board of Nursing.
For more details or to register, visit ccfcme.org/diabetesthyroid15.
Advertisement
Advertisement
Incidence, outcomes and management
Cleveland Clinic endocrinologists work to identify protocols for improving care
Cleveland Clinic’s Endocrinology & Metabolism Institute is working to offer novel opportunities and therapies for diabetes and kidney disease
New findings indicate the importance of achieving sufficient sleep levels in regard to personal glucose targets
A recent study evaluates the correlation between preoperative calcium and parathyroid hormone values as predictors of gland volume and multi-gland disease
A look at how to asses hCG elevation
As the diet’s popularity rises, certain considerations need to be taken when recommending it for patients with Type 1 diabetes
Findings suggest that the effectiveness of interventions may depend more on the frequency and delivery methods of the intervention rather than who is delivering the intervention